Table of Content




1. Introduction


2. Executive Summary

3. Market Dynamics

3.1 Growth Drivers
3.2 Challenges


4. Global - Liquid Biopsy Market


5. Market Share – Global Liquid Biopsy

5.1 By Region
5.2 By Cancer
5.3 By Product
5.4 By Circulating Biomarkers


6. Region - Liquid Biopsy Market

6.1 North America
6.2 Europe
6.3 Asia-Pacific
6.4 Latin America
6.5 Middle East & Africa


7. Cancer - Liquid Biopsy Market

7.1 Lung Cancer
7.2 Breast Cancer
7.3 Colorectal Cancer
7.4 Prostate Cancer
7.5 Others


8. By Product - Liquid Biopsy Market

8.1 Kits & Consumables
8.2 Instruments
8.3 Services


9. Circulating Biomarkers - Liquid Biopsy Market

9.1 Circulating Tumor cell (CTCs)
9.2 Circulating Tumor DNA (ctDNA)
9.3 Extracellular Vesicles (EVs)
9.4 Other Biomarkers (cell free DNA,etc)


10. By Clinical Application - Liquid Biopsy Market

10.1 Monitoring
10.2 Prognosis
10.3 Theranostics
10.4 Screening


11. By Sample - Liquid Biopsy Market

11.1 Plasma / Serum
11.2 Urine
11.3 Others


12. Company Analysis

12.1 Thermo Fisher Scientific Inc

12.1.1 Overview
12.1.2 Product Portfolio

12.2 Roche Diagnostics

12.2.1 Overview
12.2.2 Product Portfolio
12.2.3 Financial Insight

12.3 Bio-Rad Laboratories Inc

12.3.1 Overview
12.3.2 Product Portfolio
12.3.3 Financial Insight

12.4 Biocept, Inc.

12.4.1 Overview
12.4.2 Product Portfolio

12.5 Biocartis

12.5.1 Overview
12.5.2 Product Portfolio
12.5.3 Financial Insight

12.6 Myriad Genetics, Inc

12.6.1 Overview
12.6.2 Product Portfolio
12.6.3 Financial Insight

12.7 Genomic Health

12.7.1 Product Portfolio
12.7.2 Financial Insight

12.8 NeoGenomics Laboratories

12.8.1 Overview
12.8.2 Product Portfolio
12.8.3 Financial Insight

12.9 Qiagen

12.9.1 Overview
12.9.2 Product Portfolio
12.9.3 Financial Insight



List of Figures



Figure 4-1: Global – Liquid Biopsy Market (Million US$), 2015 – 2020
Figure 4-2: Global – Forecast for Liquid Biopsy Market (Million US$), 2021 – 2026
Figure 5-1: By Region – Liquid Biopsy Market Share (%), 2015 – 2020
Figure 5-2: By Region – Forecast for Liquid Biopsy Market Share (%), 2021 – 2026
Figure 5-3: By Cancer – Liquid Biopsy Market Share (%), 2015 - 2020
Figure 5-4: By Cancer – Forecast for Liquid Biopsy Market Share (%), 2021 – 2026
Figure 5-5: By Product – Liquid Biopsy Market Share (%), 2015 – 2020
Figure 5-6: By Product – Forecast for Liquid Biopsy Market Share (%), 2021 – 2026
Figure 5-7: By Circulating Biomarkers – Liquid Biopsy Market Share (%), 2015 – 2020
Figure 5-8: By Circulating Biomarkers – Forecast for Liquid Biopsy Market Share (%), 2021 – 2026
Figure 6-1: United States Cancers by rates of New Cancer Cases (Male & Female) - 2015
Figure 6-2: United States Cancers by rates of Cancer Deaths (Male & Female) - 2015
Figure 6-3: Number of cancer deaths in Mexico in 2018, by cancer type (in Thousands)
Figure 6-4: North America – Liquid Biopsy Market (Million US$), 2015 – 2020
Figure 6-5: North America – Forecast for Liquid Biopsy Market (Million US$), 2021 – 2026
Figure 6-6: Europe – Liquid Biopsy Market (Million US$), 2015 – 2020
Figure 6-7: Europe – Forecast for Liquid Biopsy Market (Million US$), 2021 – 2026
Figure 6-8: Asia-Pacific – Liquid Biopsy Market (Million US$), 2015 – 2020
Figure 6-9: Asia-Pacific – Forecast for Liquid Biopsy Market (Million US$), 2021 – 2026
Figure 6-10: Latin America – Liquid Biopsy Market (Million US$), 2015 – 2020
Figure 6-11: Latin America – Forecast for Liquid Biopsy Market (Million US$), 2021 – 2026
Figure 6-12: Middle East & Africa – Liquid Biopsy Market (Million US$), 2015 – 2020
Figure 6-13: Middle East & Africa – Forecast for Liquid Biopsy Market (Million US$), 2021 – 2026
Figure 7-1: Lung Cancer – Liquid Biopsy Market (Million US$), 2015 – 2020
Figure 7-2: Lung Cancer – Forecast for Liquid Biopsy Market (Million US$), 2021 – 2026
Figure 7-3: Breast Cancer – Liquid Biopsy Market (Million US$), 2015 – 2020
Figure 7-4: Breast Cancer – Forecast for Liquid Biopsy Market (Million US$), 2021 – 2026
Figure 7-5: Colorectal Cancer – Liquid Biopsy Market (Million US$), 2015 – 2020
Figure 7-6: Colorectal Cancer – Forecast for Liquid Biopsy Market (Million US$), 2021 – 2026
Figure 7-7: Prostate Cancer – Liquid Biopsy Market (Million US$), 2015 – 2020
Figure 7-8: Prostate Cancer – Forecast for Liquid Biopsy Market (Million US$), 2021 – 2026
Figure 7-9: Others – Liquid Biopsy Market (Million US$), 2015 – 2020
Figure 7-10: Others – Forecast for Liquid Biopsy Market (Million US$), 2021 – 2026
Figure 8-1: Kits & Consumables – Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 8-2: Kits & Consumables – Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 8-3: Instruments – Liquid Biopsy Market (Million US$), 2015 – 2020
Figure 8-4: Instruments – Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 8-5: Services – Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 8-6: Services – Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 9-1: CTCs – Liquid Biopsy Market (Million US$), 2015 – 2020
Figure 9-2: CTCs – Forecast for Liquid Biopsy Market (Million US$), 2021 – 2026
Figure 9-3: ctDNA – Liquid Biopsy Market (Million US$), 2015 – 2020
Figure 9-4: ctDNA – Forecast for Liquid Biopsy Market (Million US$), 2021 – 2026
Figure 9-5: Extracellular Vesicles – Liquid Biopsy Market (Million US$), 2015 – 2020
Figure 9-6: Extracellular Vesicles – Forecast for Liquid Biopsy Market (Million US$), 2021 – 2026
Figure 9-7: Other Biomarkers – Liquid Biopsy Market (Million US$), 2015 – 2020
Figure 9-8: Other Biomarkers – Liquid Biopsy Market (Million US$), 2021 – 2026
Figure 10-1: Monitoring – Liquid Biopsy Market (Million US$), 2015 – 2020
Figure 10-2: Monitoring – Forecast for Liquid Biopsy Market (Million US$), 2021 – 2026
Figure 10-3: Prognosis – Liquid Biopsy Market (Million US$), 2015 – 2020
Figure 10-4: Prognosis – Forecast for Liquid Biopsy Market (Million US$), 2021 – 2026
Figure 10-5: Theranostics – Liquid Biopsy Market (Million US$), 2015 – 2020
Figure 10-6: Theranostics – Forecast for Liquid Biopsy Market (Million US$), 2021 – 2026
Figure 10-7: Screening – Liquid Biopsy Market (Million US$), 2015 – 2020
Figure 10-8: Screening – Forecast for Liquid Biopsy Market (Million US$), 2021 – 2026
Figure 11-1: Plasma/Serum – Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 11-2: Plasma/Serum – Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 11-3: Urine – Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 11-4: Urine – Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 11-5: Others – Liquid Biopsy Market (Million US$), 2015 - 2020
Figure 11-6: Others – Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
Figure 12-1: Roche Diagnostics – Diagnostics Sales (Million US$), 2015 – 2020
Figure 12-2: Roche Diagnostics – Forecast for Diagnostics Sales (Billion US$), 2021 – 2026
Figure 12-3: Bio-Rad Laboratories – Net Sales (Million US$), 2015 – 2020
Figure 12-4: Bio-Rad Laboratories – Forecast for Net Sales (Million US$), 2021 – 2026
Figure 12-5: Biocept – Revenue (Million US$), 2015 – 2020
Figure 12-6: Biocept – Forecast for Revenue (Million US$), 2021 – 2026
Figure 12-7: Biocartis – Net Sales (Million US$), 2015 – 2020
Figure 12-8: Biocartis – Forecast for Net Sales (Million US$), 2021 – 2027
Figure 12-9: Myriad Genetics – Molecular Diagnostics Revenue (Million US$), 2015 – 2020
Figure 12-10: Myriad Genetics – Forecast for Molecular Diagnostics Revenue (Million US$), 2021 – 2026
Figure 12-11: NeoGenomics Laboratories – Net Sales (Million US$), 2015 – 2020
Figure 12-12: NeoGenomics Laboratories – Forecast for Net Sales (Million US$), 2021 – 2027
Figure 12-13: Qiagen – Revenue (Million US$), 2015 – 2020
Figure 12-14: Qiagen – Forecast For Revenue (Million US$), 2021 – 2027


List of Tables



Table 6?1: Estimated number of people living with cancer: by nation, at the end of 2010, 2015, 2020 and 2030
Table 6?2: Cancer Statistics Japan - 2017